Open AccessEmpagliflozin Reduces Blood Pressure in Patients With Type 2 Diabetes and Hypertension
Author(s) -
Ilkka Tikkanen,
Kirsi Narko,
Cordula Zeller,
Alexandra Green,
Afshin Salsali,
Uli C. Broedl,
Hans J. Woerle
Publication year - 2014
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc14-1096
Subject(s) - empagliflozin , medicine , diabetes mellitus , type 2 diabetes , blood pressure , cardiology , intensive care medicine , endocrinology
To investigate the efficacy, safety, and tolerability of empagliflozin in patients with type 2 diabetes and hypertension.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom